GBS Inc. (GBS) financial statements (2022 and earlier)

Company profile

Business Address 733 THIRD AVENUE
NEW YORK, NY 10017
State of Incorp. DE
Fiscal Year End June 30
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
TTM
6/30/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments11,19112,574
Cash and cash equivalents11,19112,574
Receivables1,6112,099
Other current assets1482,509
Other undisclosed current assets1,1351,025
Total current assets:14,08518,207
Noncurrent Assets
Nontrade receivables1,1513,148
Other noncurrent assets 504
Total noncurrent assets:1,1513,652
TOTAL ASSETS:15,23621,859
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:4491,570
Employee-related liabilities129 
Other undisclosed accounts payable and accrued liabilities3201,570
Deferred revenue3,4222,099
Due to related parties1013
Other undisclosed current liabilities129 
Total current liabilities:4,0093,683
Noncurrent Liabilities
Liabilities, other than long-term debt1,1513,148
Deferred revenue1,1513,148
Other undisclosed noncurrent liabilities3122
Total noncurrent liabilities:1,1823,170
Total liabilities:5,1916,853
Stockholders' equity
Stockholders' equity attributable to parent10,10515,058
Preferred stock 13
Common stock149136
Additional paid in capital38,44038,440
Accumulated other comprehensive loss(721)(661)
Accumulated deficit(27,762)(22,870)
Stockholders' equity attributable to noncontrolling interest(60)(51)
Total stockholders' equity:10,04515,007
TOTAL LIABILITIES AND EQUITY:15,23621,859

Income statement (P&L) ($ in thousands)

12/31/2021
TTM
6/30/2021
Revenues1,8201,980
Gross profit:1,8201,980
Operating expenses(10,719)(7,554)
Operating loss:(8,899)(5,573)
Nonoperating income (expense)5(1,487)
Foreign currency transaction loss, before tax(265) 
Interest and debt expense(22)(1,094)
Loss from continuing operations before equity method investments, income taxes:(8,916)(8,154)
Other undisclosed income from continuing operations before income taxes221,094
Net loss:(8,895)(7,060)
Net income attributable to noncontrolling interest2123
Net loss available to common stockholders, diluted:(8,873)(7,037)

Comprehensive Income ($ in thousands)

12/31/2021
TTM
6/30/2021
Net loss:(8,895)(7,060)
Other comprehensive loss(262) 
Other undisclosed comprehensive loss(79)(297)
Comprehensive loss:(9,235)(7,358)
Comprehensive income, net of tax, attributable to noncontrolling interest2123
Comprehensive loss, net of tax, attributable to parent:(9,214)(7,335)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: